Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Diagnostics In Spotlight As UK Launches ‘World-First’ Whole Genome Testing Service

Executive Summary

Health care authorities in the UK made several medtech-related announcements this week, one of which is its “groundbreaking” genetic testing service that is set to expedite rare disease diagnosis for babies and children in England.

You may also be interested in...



UK Rolls Out Genetic Testing Program For Lynch Syndrome In Cancer Prevention Push

The National Health Service in England is rolling out an innovative genetic testing program for Lynch syndrome in all people diagnosed with bowel and endometrial cancer, as well as their family members, in a bid to prioritize prevention and early diagnosis.

UK Has ‘Much Room For Improvement’ On Genomic Testing Access

UK patient outcomes would improve under clearer, standardized market access or reimbursement pathways for advanced diagnostic tests, such as those used to screen for cancer, trade groups say.

UK’s MHRA Gets £1.8 Million Charity Boost To Develop Mental Health App Regulation

The UK has yet to announce its new medical device regulations, much to the concern of industry. However, the MHRA has received a £1.8 million ($2m) funding boost from charitable research foundation for a regulatory development project focused on digital mental health apps.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT145933

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel